N-hydroxyamide derivatives and use thereof
    3.
    发明授权
    N-hydroxyamide derivatives and use thereof 有权
    N-羟基酰胺衍生物及其用途

    公开(公告)号:US07868009B2

    公开(公告)日:2011-01-11

    申请号:US11883286

    申请日:2006-01-27

    CPC分类号: C07D295/185 C07D317/34

    摘要: The present invention is related to N-hydroxyamide derivatives of Formula (I): and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.

    摘要翻译: 本发明涉及式(I)的N-羟基酰胺衍生物:其特别用于治疗和/或预防自身免疫疾病,炎性疾病,心血管疾病,神经变性疾病,癌症,呼吸系统疾病和纤维化,包括多种 硬化症,关节炎,肺气肿,慢性阻塞性肺病,肝纤维化和肺纤维化。

    Aryl dicarboxamides
    5.
    发明授权
    Aryl dicarboxamides 失效
    芳基二甲酰胺

    公开(公告)号:US07365225B2

    公开(公告)日:2008-04-29

    申请号:US10565557

    申请日:2004-07-20

    摘要: The present invention is related to aryl dicarboxamides of formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholes-terolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of aryl dicarboxamides of formula (I) to modulate, notably to inhibit the activity of PTPs. A is an aminocarbonyl moiety; Cy is an aryl, heteroaryl, aryl-heteroaryl, heteroaryl-aryl, aryl-aryl, cycloalkyl or heterocycle group; n is either 0 or 1; R1 and R2 are independently from each other is selected from the group consisting of hydrogen or C1-C6-alkyl; R4 and R5 are each independently from each other selected from the group consisting of H, hydroxy, C1-C6 alkyl, carboxy, C1-C6 alkoxy, C1-C3 alkyl carboxy, C2-C3 alkenyl carboxy, C2-C3 alkynyl carboxy, amino or R4 and R5 may form an unsaturated or saturated heterocyclic ring, whereby at least one of R4 or R5 is not a hydrogen or C1-C6 alkyl

    摘要翻译: 本发明涉及式(I)的芳基二甲酰胺和其用于治疗和/或预防由胰岛素抵抗或高血糖介导的肥胖和/或代谢障碍的用途,其包括I型和/或II型糖尿病,葡萄糖耐量不足, 胰岛素抵抗,高脂血症,高甘油三酯血症,高胆固醇血症,多囊卵巢综合征(PCOS)。 特别地,本发明涉及式(I)的芳基二羧酰胺调节,特别是抑制PTP活性的用途。 A是氨基羰基部分; Cy是芳基,杂芳基,芳基 - 杂芳基,杂芳基 - 芳基,芳基 - 芳基,环烷基或杂环基团; n为0或1; R 1和R 2彼此独立地选自氢或C 1 -C 6烷基, 亚烷基; R 4和R 5各自彼此独立地选自H,羟基,C 1 -C 6 羧基,C 1 -C 6烷氧基,C 1 -C 3烷基羧基,C 1 -C 6烷基,C 1 -C 6烷基, ,C 2 -C 3链烯基羧基,C 2 -C 3炔基羧基,氨基或R SUP > 4和R 5可以形成不饱和或饱和的杂环,其中R 4或R 5中的至少一个是 不是氢或C 1 -C 6烷基

    N-Hydroxyamide Derivatives and Use Thereof
    6.
    发明申请
    N-Hydroxyamide Derivatives and Use Thereof 有权
    N-羟基酰胺衍生物及其用途

    公开(公告)号:US20080090838A1

    公开(公告)日:2008-04-17

    申请号:US11883286

    申请日:2006-01-27

    CPC分类号: C07D295/185 C07D317/34

    摘要: The present invention is related to N-hydroxyamide derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic 5 obstructive pulmonary disease, liver and pulmonary fibrosis.

    摘要翻译: 本发明涉及式(I)的N-羟基酰胺衍生物及其用途,特别是其用于治疗和/或预防自身免疫疾病,炎性疾病,心血管疾病,神经变性疾病,癌症,呼吸系统疾病和纤维化,包括多发性硬化症 ,关节炎,肺气肿,慢性5型阻塞性肺疾病,肝纤维化和肺纤维化。

    Octahydropyrrolo[2,3C]Pyridine Derivatives and Pharmaceutical Use Thereof
    10.
    发明申请
    Octahydropyrrolo[2,3C]Pyridine Derivatives and Pharmaceutical Use Thereof 有权
    八氢吡咯并[2,3C]吡啶衍生物及其药物用途

    公开(公告)号:US20080146806A1

    公开(公告)日:2008-06-19

    申请号:US11658084

    申请日:2005-07-20

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: The present invention is related to octahydropyrrolo[2,3,c]pyridine derivatives of Formula (I) and use thereof in particular for the treatment and/or prophylaxis of autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, cancer, respiratory diseases and fibrosis, including multiple sclerosis, arthritis, emphysema, chronic obstructive pulmonary disease, liver and pulmonary fibrosis.

    摘要翻译: 本发明涉及式(I)的八氢吡咯并[2,3,c]吡啶衍生物,特别是其用于治疗和/或预防自身免疫性疾病,炎性疾病,心血管疾病,神经变性疾病,癌症,呼吸系统疾病 和纤维化,包括多发性硬化,关节炎,肺气肿,慢性阻塞性肺病,肝纤维化和肺纤维化。